Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Growth factor release from amylopectin hydrogel based on copper coordination

Y Tabata1, Y Matsui, Y Ikada

  • 1Research Center for Biomedical Engineering, Kyoto University, 53 Kawahara-cho Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.

Journal of Controlled Release : Official Journal of the Controlled Release Society
|November 5, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sealing effects of cross-linked gelatin.

Journal of biomaterials applications·2012
Same author

Characteristics of a New Liquid Material for Arteriovenous Malformations (HEMA-MMA).

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences·2010
Same author

Embolization of aneurysms with a liquid material. An experimental study.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences·2010
Same author

7th taniguchi conference on polymer chemistry tissue engineering with the use of biomedical polymers: introduction.

Tissue engineering·2009
Same author

Review of acellular and cellular artificial skins.

Tissue engineering·2009
Same author

Permeability of filters used for immunoisolation.

Tissue engineering·2009
Same journal

Metabolic regulation-driven nanoparticles for tumor vulnerabilization and enhanced photodynamic therapy.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

New approach methodologies (NAMs) for preclinical and translational evaluation of mRNA-lipid nanoparticle (LNP) therapeutics.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

A cation-free platform based on azocalixarene poly(disulfide)s for direct cytosolic protein delivery.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

Harnessing plant-derived extracellular vesicles for oral delivery: A dual role as natural therapeutics and engineered drug carriers.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

Hijacking radiotherapy-induced chemokines with self-assembled molecular decoys for glioblastoma radio-immunotherapy.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same journal

A one-step surface engineering strategy based on PEG-EGCG to improve systemic delivery and survival of transplanted mesenchymal stromal cells.

Journal of controlled release : official journal of the Controlled Release Society·2026
See all related articles

This study presents a biodegradable hydrogel that stabilizes and releases basic fibroblast growth factor (bFGF) using copper chelation. This method promotes prolonged neovascularization by controlling bFGF release through hydrogel degradation.

Area of Science:

  • Biomaterials Science
  • Tissue Engineering
  • Drug Delivery Systems

Background:

  • Biodegradable hydrogels are promising for controlled drug release.
  • Stabilizing growth factors like basic fibroblast growth factor (bFGF) is crucial for effective therapeutic applications.
  • Protein metal coordination offers a novel approach for hydrogel-based drug delivery.

Purpose of the Study:

  • To develop a biodegradable amylopectin hydrogel matrix for controlled release of basic fibroblast growth factor (bFGF).
  • To investigate the role of copper (Cu2+) chelation and diethylenetriaminepentaacetic acid (DTPA) in bFGF stabilization and release.
  • To evaluate the in vivo efficacy of the hydrogel system for promoting neovascularization.

Main Methods:

  • Preparation of a biodegradable amylopectin hydrogel crosslinked with ethylene glycol diglycidyl ether.

Related Experiment Videos

  • Introduction of DTPA residues for copper chelation.
  • Incorporation of bFGF via Cu2+ chelation into the DTPA-modified hydrogel.
  • In vitro release studies under varying ionic strengths.
  • In vivo degradation and neovascularization studies using 125I-labeled hydrogels in mice.

    • Main Results:

    • Cu2+ chelation significantly reduced bFGF release, indicating stable coordinate bonding.
    • The hydrogels demonstrated biodegradation in vivo.
    • DTPA-modified hydrogels with Cu2+-chelated bFGF promoted significant neovascularization.
    • DTPA prevented Cu2+-induced deactivation of bFGF, ensuring biological activity.

    Conclusions:

    • A DTPA-introduced amylopectin hydrogel system effectively stabilizes biologically active bFGF through Cu2+ chelation.
    • The hydrogel facilitates sustained bFGF release upon biodegradation, leading to prolonged neovascularization.
    • This approach offers a promising strategy for enhanced tissue regeneration therapies.